NEWS & EVENTS
PRESS RELEASES 2006
December 13th, 2006
|
Elusys and U.S. Army Extend Biodefense Collaboration
|
October 16th, 2006
|
Elusys Announces fall 2006 conference schedule
|
September 28th, 2006 |
Elusys Presents Positive Data on Anthrax Therapeutic at ICAAC
|
July 13th, 2006
|
Elusys Therapeutics Completes $23 Million Series D Venture Financing
|
June 21st, 2006
|
Elusys' Anthrax Therapeutic, Anthim™, Granted FDA Orphan Drug Designation
|
| April 20th, 2006 | Elusys Enters into Infectious Disease License and Collaboration Agreement with Medimmune, Inc.
|
march 29th, 2006 |
Elusys Therapeutics Successfully Completes Human Clinical Study of Anthrax Therapeutic, Anthim™
|
february 16th, 2006 |
Elusys’ Anthrax Drug, Anthim™, Superior to Antibiotic as a Post-Exposure Monotherapy
|
february 13th, 2006 |
|
january 24th, 2006
|
Elusys Therapeutics’ CEO to Present at Anti-Infectives Industry Summit |